Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant APP (Ponezumab Biosimilar) antibody

The Humanized Chimeric anti-APP (Ponezumab Biosimilar) antibody has been validated for not_set. It is suitable to detect APP (Ponezumab Biosimilar) in samples from Human.
Catalog No. ABIN7597918
-15% Promotion 2026
$340.97
$401.14
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant APP (Ponezumab Biosimilar) antibody (ABIN7597918)

Target

APP (Ponezumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
Humanized

Clonality

  • 1
Chimeric

Conjugate

  • 1
This APP (Ponezumab Biosimilar) antibody is un-conjugated

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Research Grade Ponezumab Biosimilar Antibody

    Specificity

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    Purification

    Protein A or G purified from cell culture supernatant.

    Purity

    >95 % by SDS-PAGE.

    Isotype

    IgG2 kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

    Expiry Date

    12 months
  • Target

    APP (Ponezumab Biosimilar)

    Alternative Name

    Ponezumab Biosimilar

    Target Type

    Biosimilar

    Background

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    UniProt

    P05067

    CAS-No

    1178862-65-1
You are here:
Chat with us!